- Home
- EB vs CERS Comparison
EB vs CERS Comparison
Compare EB & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EB
- CERS
- Stock Information
- Founded
- EB 2008
- CERS 1991
- Country
- EB United States
- CERS United States
- Employees
- EB N/A
- CERS N/A
- Industry
- EB EDP Services
- CERS EDP Services
- Sector
- EB Technology
- CERS Technology
- Exchange
- EB Nasdaq
- CERS Nasdaq
- Market Cap
- EB 321.9M
- CERS 324.3M
- IPO Year
- EB 2018
- CERS 1997
- Fundamental
- Price
- EB $3.51
- CERS $1.72
- Analyst Decision
- EB Buy
- CERS Buy
- Analyst Count
- EB 6
- CERS 3
- Target Price
- EB $6.70
- CERS $3.17
- AVG Volume (30 Days)
- EB 1.8M
- CERS 2.0M
- Earning Date
- EB 11-07-2024
- CERS 10-30-2024
- Dividend Yield
- EB N/A
- CERS N/A
- EPS Growth
- EB N/A
- CERS N/A
- EPS
- EB N/A
- CERS N/A
- Revenue
- EB $336,368,000.00
- CERS $176,229,000.00
- Revenue This Year
- EB $1.75
- CERS $26.47
- Revenue Next Year
- EB $6.99
- CERS $11.48
- P/E Ratio
- EB N/A
- CERS N/A
- Revenue Growth
- EB 8.54
- CERS 14.71
- 52 Week Low
- EB $2.51
- CERS $1.38
- 52 Week High
- EB $9.20
- CERS $2.59
- Technical
- Relative Strength Index (RSI)
- EB 59.73
- CERS 47.71
- Support Level
- EB $3.44
- CERS $1.59
- Resistance Level
- EB $3.93
- CERS $2.03
- Average True Range (ATR)
- EB 0.24
- CERS 0.14
- MACD
- EB 0.03
- CERS 0.02
- Stochastic Oscillator
- EB 48.80
- CERS 39.22
About EB Eventbrite Inc.
Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. It is engaged in creating a platform to enable creators to solve many challenges associated with creating live experiences. The Company's platform integrates components needed to seamlessly plan, promote and produce live events. Its platform helps to plan, promote and produce live events, thereby allowing creators to reduce friction and costs, increase reach and drive ticket sales. Geographically, it generates maximum revenue from the United States.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.